Abstract

Two mononuclear vanadium(V) complexes, [VOL1(KA)] (I) and [VOL2(EM)] (II), where L1 and L2 are the dianionic form of N'-(3-ethoxy-2-hydroxybenzylidene)-4-methoxybenzohydrazide (H2L1) and 4-bromo-N'-(3-ethoxy-2-hydroxybenzylidene)benzohydrazide (H2L2), respectively; KA and EM are the monoanionic form of kojic acid and ethyl maltol, respectively, were prepared. The complexes were characterized by elemental analysis, IR and UV-Vis spectra, and single crystal X-ray determination (CIF files CCDC nos. 1823339 (I) and 1823341 (II)). The crystal of complex I crystallizes in the triclinic space group P–1 with unit cell a = 7.7813(16), b = 11.297(2), c = 14.3390(18) A, α = 90.449(2)°, β = 100.402(2)°, γ = 108.366(2)°, V = 1173.8(4) A3, Z = 2. The crystal of complex II crystallizes in the monoclinic space group P21/n with unit cell a = 8.6935(5), b = 30.9695(18), c = 18.4469(11) A, β = 99.366(2)°, V = 4900.3(5) A3, Z = 8. The V atoms in the complexes are in octahedral geometry. The antimicrobial activities of the compounds against K. pneumoniae, S. aureus, P. aeroginosa, E. coli, and B. subtilis were investigated.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.